Gilead Sciences Inc. (GILD) — Form 144: Proposed sale of shares

Director and Officer DANIEL O'DAY of Gilead Sciences Inc. proposed to sell 45,881 common shares with an aggregate market value of $7,598,352.41 through Morgan Stanley Smith Barney LLC Executive Financial Services. The proposed sale date is October 30, 2026. The shares to be sold come from a stock option exercise of 15,881 shares on October 30, 2026, and 30,000 performance stock units acquired on February 4, 2025. The transaction is associated with a trading plan adopted on February 25, 2026.